Carl Saling - The Cannabis Investor

Hollister Launches New Tommy Chong’s Cannabis 1:1 Full-Spectrum Elixir

Hollister Biosciences Announced the Official California Launch of its Highly-Anticipated Tommy Chong's Cannabis 1:1 Full-Spectrum Elixir The New Full-Spectrum Elixir Will Complement Hollister's Lineup of Popular Cannabis Products, Which Includes... read more →

May 29, 2020
Ryan T.

Hollister Biosciences Closes Acquisition of Psychedelics Company AlphaMind

The AlphaMind Acquisition is a Milestone Moment for the Rapidly Ascending Cannabis Company With the Transformational Deal Now Complete, Hollister Has Officially Diversified into the Flourishing World of Psychedelics Hollister... read more →

May 4, 2020
Ryan T.

Cannabis MSO Hollister Firms Up Deal to Acquire Psychedelics Company AlphaMind

Hollister Biosciences, One of the Hottest Names in Cannabis, is Moving Forward with Another Blockbuster Deal Following its Recent Acquisition of Venom Extracts Hollister Announced That it Reached a Definitive... read more →

April 26, 2020
Ryan T.

Hollister Biosciences Closes Transformational Venom Extracts Acquisition, Psychedelics Deal Up Next

The Highly Accretive Acquisition Strengthens Hollister's Brand Portfolio While Expanding its Footprint Across Multiple U.S. States Venom Extracts Brings With it 2019 EBITDA of $2.5 Million on Revenue of $16.4... read more →

March 30, 2020
Ryan T.

Hollister Biosciences to Enter Booming Psychedelics Sector Through Psilocybin Acquisition

Hollister Biosciences Signs LOI to Acquire Legal Medicinal Mushroom and Psilocybin Firm Alphamind Brands Alphamind is Developing Mushroom Products and Conducting R&D for Psilocybin Pharmaceutical Applications Hollister Biosciences (CSE: HOLL)... read more →

March 11, 2020
Ryan T.

Hollister Biosciences to Acquire Premier Cannabis Extract Brand Venom Extracts

Hollister Biosciences Signs LOI to Acquire Venom Extracts, One of Arizona's Premier Cannabis Extract and Distillate Brands The Award-Winning Venom Extracts Generated EBITDA of $2.48 Million on Revenue of $16.4... read more →

February 25, 2020
Ryan T.

Hollister Biosciences’ Rebel Hemp to Launch Line of Premium Hemp Pre-Rolls + HOLL Stock Chart Review

New Rebel Hemp Products to Join Hollister Biosciences' #1 California Hash Infused Pre-Roll Brand "HashBone" Updated Technical Analysis Review of HOLL Stock Price Action and Chart Hollister Biosciences (CSE: HOLL)... read more →

February 19, 2020
Ryan T.

Hollister Biosciences and Cannabis Legend Tommy Chong Sign Licensing Deal, HOLL Stock Soars to New Highs

Hollister Biosciences to Manufacture and Distribute Tommy Chong's Cannabis™ Full Spectrum Elixir 1:1 HOLL Stock Jumps 25% on Earlier News of Planned Tactical Relief JV to Create Tinctures for Veterans... read more →

February 7, 2020
Shawn V.

VIDEO: TCI CEO Interview with Carl Saling of Hollister Biosciences | CSE: HOLL FRA: HOB

Hollister's CEO Gives Investors an Inside Look at the Company Set to Shine in the World's Largest Cannabis Market TCI host Alyssa Boston (Miss Universe Canada 2019 + Cannabis Crusader)... read more →

February 5, 2020
Ryan T.